Ruplizumab (Anti-TNFSF5 / CD40L / CD154)

Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.

• Supplier: Selleck Chemicals
• Product #: A3100
• Sku #: A3100-1mg*25